Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
Association of two mutations in the CHEK2 gene with breast cancer.
|
15810020 |
2005 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
CLINVAR |
BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
|
22811390 |
2013 |
Papillary thyroid carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
Case report of a woman with monoclonal gammapathy and papillary thyroid carcinoma, diagnosed because of detection of CHEK2 (I157T) mutation in genetic examinations.
|
21049466 |
2011 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
CLINVAR |
Characterization of CHEK2 mutations in prostate cancer.
|
16835864 |
2006 |
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
Characterization of tumor-associated Chk2 mutations.
|
11053450 |
2001 |
Malignant neoplasm of colon and/or rectum
|
|
0.070 |
GeneticVariation
|
BEFREE |
CHEK2 I157T associates with familial and sporadic colorectal cancer.
|
16816021 |
2006 |
Colorectal Carcinoma
|
|
0.090 |
GeneticVariation
|
BEFREE |
CHEK2 I157T associates with an increased risk of CRC: the association was observed both among familial and sporadic CRC patients.
|
16816021 |
2006 |
Familial (FPAH)
|
|
0.030 |
GeneticVariation
|
BEFREE |
CHEK2 I157T associates with an increased risk of CRC: the association was observed both among familial and sporadic CRC patients.
|
16816021 |
2006 |
Malignant neoplasm of colon and/or rectum
|
|
0.070 |
GeneticVariation
|
BEFREE |
CHEK2 I157T and colorectal cancer in Bulgaria.
|
20658728 |
2010 |
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
CHEK2 I157T associates with familial and sporadic colorectal cancer.
|
16816021 |
2006 |
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
CHEK2 is a multiorgan cancer susceptibility gene.
|
15492928 |
2004 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
CLINVAR |
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
|
18725978 |
2008 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
CLINVAR |
CHEK2 mutations and HNPCC-related colorectal cancer.
|
19876921 |
2010 |
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
CHEK2 mutations and HNPCC-related colorectal cancer.
|
19876921 |
2010 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
CLINVAR |
CHEK2 mutations and the risk of papillary thyroid cancer.
|
25583358 |
2015 |
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
CHEK2 mutations and the risk of papillary thyroid cancer.
|
25583358 |
2015 |
Neoplastic Syndromes, Hereditary
|
|
0.700 |
CausalMutation
|
CLINVAR |
CHEK2 variant I157T may be associated with increased breast cancer risk.
|
15239132 |
2004 |
Adult Hepatocellular Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
CHK2 1100delC, IVS2+1G>A and I157T mutations are not present in hepatocellular cancer cases from a Turkish population.
|
23107771 |
2013 |
Malignant neoplasm of liver
|
|
0.010 |
GeneticVariation
|
BEFREE |
CHK2 1100delC, IVS2+1G>A and I157T mutations are not present in hepatocellular cancer cases from a Turkish population.
|
23107771 |
2013 |
Childhood Hepatocellular Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
CHK2 1100delC, IVS2+1G>A and I157T mutations are not present in hepatocellular cancer cases from a Turkish population.
|
23107771 |
2013 |
Luminal A Breast Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
Comparing the prevalence of CHEK2 mutations in BC with controls revealed that carriers of an I157T variant had OR of 1.80 for luminal A subtype and carriers of truncating mutations had OR of 6.26 for luminal B subtype of BC.
|
21701879 |
2012 |
Breast Carcinoma
|
|
0.900 |
GeneticVariation
|
BEFREE |
Comparing the prevalence of CHEK2 mutations in BC with controls revealed that carriers of an I157T variant had OR of 1.80 for luminal A subtype and carriers of truncating mutations had OR of 6.26 for luminal B subtype of BC.
|
21701879 |
2012 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
BEFREE |
Comparing the prevalence of CHEK2 mutations in BC with controls revealed that carriers of an I157T variant had OR of 1.80 for luminal A subtype and carriers of truncating mutations had OR of 6.26 for luminal B subtype of BC.
|
21701879 |
2012 |
Breast Carcinoma
|
|
0.900 |
GeneticVariation
|
BEFREE |
Despite the lack of association of I157T mutation with breast cancer development in our population we deduced that the FHA domain is the subject of rare population-specific alterations that might modify risk of various cancers.
|
18058223 |
2008 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
BEFREE |
Despite the lack of association of I157T mutation with breast cancer development in our population we deduced that the FHA domain is the subject of rare population-specific alterations that might modify risk of various cancers.
|
18058223 |
2008 |